期刊文献+

血浆EB病毒DNA数量与鼻咽癌细胞凋亡的相关性分析 被引量:4

An Analysis on Relationship between Plasma EBV-DNA Copy and Cell Apoptosis in Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的探讨血浆EBV-DNA数量与鼻咽癌细胞凋亡的关系。方法采用巢式荧光定量PCR,检测鼻咽癌患者血清EBV-DNA的拷贝数,TUNEL法检测鼻咽癌组织中癌细胞凋亡情况,分析EBV-DNA拷贝数与凋亡癌细胞的相关性。结果鼻咽癌患者血浆EBV-DNA检出率为96.4%(27/28),中位数为1 800 copies/μl(0~22 100 copies/μl)。28例鼻咽癌活检组织中癌细胞平均凋亡指数为30.0±18.0。EBV-DNA拷贝数与鼻咽癌细胞凋亡呈正相关(γ=0.927,P<0.05)。结论血浆EBV-DNA水平与鼻咽癌细胞凋亡呈正相关,鼻咽癌患者血浆EBV-DNA可能部分来源于凋亡的癌细胞。 Objective To analyze the relationship between plasma EBV-DNA copy and nasopharyngeal carcinoma(NPC) cell apoptosis.Methods EBV-DNA in 28 plasma samples from patients with NPC was detected by using fluorescent quantitative nested-PCR.Apoptosis NPC cells were detected in biopsy samples from these patients using TUNEL assay kit.The relationship was analyzed between plasma EBV-DNA copies and apoptosis cell numbers.Results 27 of 28 plasma samples were positive,the positive rate was 96.4% and the EBV-DNA median concentration was 1 800 copies /μl(range:0~22 100 copies /μl).Apoptosis index of NPC biopsy samples was 30.0±18.0.EBV-DNA copy numbers were positively associated apoptosis indexes(γ = 0.927,P0.05).Conclusion EBV-DNA levels were associated with apoptosis index,and this implies that plasma EBV-DNA might come from NPC cell apoptosis.
出处 《实用癌症杂志》 2011年第1期4-6,15,共4页 The Practical Journal of Cancer
基金 国家自然科学基金(30572455 30973400 81000881) 湖南省科技厅计划项目(2009WK3060)
关键词 细胞凋亡 鼻咽癌 Apoptosis Nasopharyngeal carcinoma
  • 相关文献

参考文献14

  • 1Afqir S, Ismaili N, Errihani H. Concurrent chemoradiothera- py in the management of advanced nasopharyngeal carcino- ma:current status[ J]. J Cancer Res Ther,2009,5 ( 1 ) :3.
  • 2Zou P, Kawada J, Pesnicak L,et al. Bortezomib induces ap- optosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-trans- formed B cells[ J]. J Virol,2007,81 (18) : 10029.
  • 3Lin JC, Wang WY, Liang WM, et al. Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy [ J ]. Int J Radiat Oncol Biol Phys,2007,68 ( 5 ) : 1342.
  • 4Takakuwa T, Luo WJ, Ham MF, et al. Integration of Ep- stein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression[ J]. Am J Pathol, 2004,164 ( 3 ) :967.
  • 5Ahsan N, Kanda T, Nagashima K, et al. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus pro- duction [ J ]. J Virol, 2005,79 ( 7 ) :4415.
  • 6Leung SF, Tam JS, Chan AT, et al. Improved accuracy of detection of nasopharyngeal carcinoma by combined appli- cation of circulating Epstein-Barr virus DNA and anti-Ep- stein-Barr viral capsid antigen IgA antibody [ J ]. Clin Chem, 2004,50 ( 2 ) : 339.
  • 7Incomserb P, Bhattarakosol P, Kulwichit W, et al. Establish- ment of real-time polymerase chain reaction-based assay for quantitation of Epstein-Barr virus DNA in healthy donors and in patients with EBV associated lymphoma [ J]. J Med Assoc Thai, 2005,88 ( 4 ) : $280.
  • 8Lo YM. Quantitative analysis of Epstein-Barr virus DNA in plasma and serum:applications to tumor detection and mo- nitoring( J). Ann NY Acad Sci ,2001,945 ( 8 ) :68.
  • 9祝晓芬,杜宝文,黄小明,林世棠,蓝玉宏.血浆EB病毒DNA含量定量检测对鼻咽癌的诊断和预后评价[J].中国中西医结合耳鼻咽喉科杂志,2006,14(2):73-75. 被引量:13
  • 10Shotelersuk K, Khorprasert C, Sakd IKUL S, et al. Epstein- Barr virus DNA in serum/plasma as a tumormarker for na- sopharyngeal cancer [ J ].Clin Cancer Res, 2000,6 ( 3 ) : 1046.

二级参考文献27

  • 1陈小毅,孙宁.良、恶性鼻咽活检组织中EB病毒DNA检测、EBNA的分型及表达[J].中华病理学杂志,1994,23(4):200-203. 被引量:5
  • 2游绍进,姚开泰,曹亚,胡维新.Epstein-Barr病毒潜伏状态与鼻咽癌的关系[J].中华肿瘤杂志,1996,18(1):23-26. 被引量:21
  • 3蒋金荃 胡利富 等.EBV基因片段在鼻咽癌病人外周血白细胞DNA中存在的意义[J].癌症,1987,6(1):10-10.
  • 4邵细芸 陈主初 等.鼻咽癌Epstein-Barr病毒受体(EBVR/CR2)基因的病毒结合区的序列测定.中国癌症研究进展(二)[M].北京:北京医科大学中国协和医科大学联合出版社,1996.97.
  • 5SWAMINATHAN R, BUTT A N. Circulating nucleic acids in plasma and serum: recent developments [ J ]. Ann N Y Acad Sci, 2006. 1 075:1 -9.
  • 6NAWROZ H, KOCH W, ANKER P, et al. Microsatellite alterations in serum DNA of head and neck -cancer patients[ J]. Nature (Med), 1996, 2(9): 1 035- 1 037.
  • 7ANKER P, MULCAHY H, CHEN X Q, et al. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients[ J ]. Cancer Metastasis Rev, 1999, 18 ( 1 ) : 65 - 73.
  • 8SCHMILOVITZ WEISS H, STEMMER S M, LIBERZON E, et al. Quantitation of alpha - fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study[J]. Cancer Detect Prev, 2006, 30(2) : 204 -209.
  • 9CARRILLO E, PRADOS J, MARCHAL J A, et al. Prognostic value of RT - PCR tymsinase detection in peripheral blood of melanoma patients[J]. Dis Markers, 2006, 22(3) : 175 - 181.
  • 10SHOTELERSUK K, KHORPRASERT C, SAKDIKUL S, et al. Epstein - Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer [ J ]. Clin Cancer Res, 2000, 6 ( 3 ) : 1 046- 1 051.

共引文献27

同被引文献59

  • 1吴少雄,赵充,崔念基,卢泰祥,邓美玲,黄莹.诱导化疗在局部晚期鼻咽癌放射治疗中的价值[J].肿瘤防治杂志,2004,11(12):1289-1292. 被引量:12
  • 2李宇红,邵建永,冯惠霞,郜红艺,张力,管忠震,曾益新.鼻咽癌患者血浆游离EBV/DNA的定量检测及其临床意义[J].中国肿瘤临床,2004,31(8):421-424. 被引量:37
  • 3杨德辉,柳青.鼻咽癌患者血浆游离EBVDNA检测的研究现状[J].中山大学研究生学刊(自然科学与医学版),2006,27(1):1-6. 被引量:4
  • 4侯雪,张力,赵充,李苏,卢丽霞,韩非,邵建永,黄培钰.血浆EB病毒DNA浓度预测鼻咽癌远处转移的研究[J].癌症,2006,25(7):785-792. 被引量:28
  • 5TWU C W, WANG W Y, LIANG W M, et al. Comparison the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma [ J ] . Int J Radiat Oncol Biol Phys, 2007, 67(1 ): 130-137.
  • 6MUTIRANGURA A, PPRNTHANAKASEM W0 THEAMBOONLERS A, et al. Epstein-hart viral DNA in serum of patients with nasopharyngeal carcinoma [ J ] . Clin Cancer Res, 1998, 4 (3): 665-669.
  • 7LIN J C, WANG W Y, CHEN K Y, et al. Quantification of plasma epstein-barr virus DNA in patients with advanced nasopharyngeal carcinoma [ J ] . N Engl J Med, 2004, 350(24): 350.
  • 8BAIZIG N M, MORAND P, SEIGNEURIN J M, et al. Complementary determination of epstein-barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia [ J ] . Eur Arch Oto-Rhinol, 2012, 269(3): 1005-1011.
  • 9CHAN A T C, BRIGETTE B Y M, LO Y M, et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring [ J ] . J Cliu Oncol, 2004, 22(15): 3053-3060.
  • 10LEUNG S, JOHN S T, CHAN A T C, et al. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating epstein-barr virus DNA and anti- epstein-barr viral capsid antigen IgA antibody [ J ]. Clin Chem, 2004, 50(2): 339-345.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部